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Abstract
The notion “asthma-COPD cross” (ACC) for patients with clinical signs of bronchial asthma and COPD was introduced. 
From 15 to 45 % of population with bronchial obstructive diseases suffer from ACC and its prevalence increases with age. 
According to the data of epidemiological studies, in average a half of patients with BA in the world cannot reach a control of 
BA or keep it for a long time. 
The aim of our research was the determination of the control level and also assessment of symptoms of the disease of patients 
with BA and COPD. 
Patients. The study included patients with ACC, older than 30 years. The control included patients with the bronchial asthma 
and COPD without any signs of these pathologies combination. 
Methods. All patients underwent the spirography with the analysis of the curve “flow-volume” of a force exhalation and also 
bodypletizmography (“MasterScreenPneumo”, «CardinalHealth» (Germany)). Al patients were interrogated by the questionnaires: 
questionnaire for BA symptoms control (ACQ-7), test for BA control (ACT), test for COPD assessment CAT). 
Results. At comparing parameters of BA control was revealed the reliably worse control in the group of patients with the 
associated pathology by data of the questionnaire ACQ-7 comparing with patients with BA. The influence of COPD symptoms was 
also more essential in patients with ACC comparing with one with COPD. 
At the more expressed degree of the bronchial obstruction, BA control was reliably weaker, whereas the influence of COPD 
symptoms was more essential. 
In patients with ACC with the unsatisfactory control of BA (АСQ-7 ≥1,5 points) the mortality prognosis, expressed by BODE 
index, grows almost in 3 times; inpatients with the severe and very severe influence of the disease effect (САТ > 20 points), the mor-
tality prognosis grows more than in 2 times. 
The reliable positive correlation was revealed between the results of CAT and ratio of the internal thoracic volume of gases 
to the total capacity of lungs (ITGV/TLС), that reflects the degree of lungs hyperinflation − (r=0,35; p<0,05). 
Conclusions. At BA and COPD combination the indices of the disease control are worse than at the bronchial asthma and a 
bit similar to ones at COPD. 
Indices of BA control and influence of COPD symptoms on the condition of patients with the associated pathology were 
mainly negatively changed at the increase of the bronchial obstruction degree. 
The essential negative influence of the insufficient BA control and the high influence of COPD symptoms on the disease 
prognosis in patients with associated pathology (BA+COPD) were revealed. 
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1. Introduction
In the world near 1 of 12 persons suffers from the bronchial asthma (BA) or COPD, and 
if earlier these two nosologies were considered as two different diseases, for today it is generally 
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accepted, that they are heterogenic and often crossed. The notion “asthma-COPD cross” (ACC) for 
patients with clinical signs of the bronchial asthma and COPD was introduced.  From 15 to 45 % 
of population with bronchial obstructive diseases suffer from ACC and its prevalence increases 
with age [1, 2]. 
According to the data of epidemiological studies, in average a half of patients with BA in the 
world cannot reach a control of BA or keep it for a long time. 
In studies are demonstrated essential losses of the health protection system, connected with 
the persisting BA [3]. Also in literature are presented data about the close connection of the disease 
control with the life prognosis in future [4]. In separate works the bad BA was associated not only 
with the worse prognosis but also with the patients’ life quality decrease [5, 6]. It is also not a sur-
prise that the insufficient BA control is an essential medical-social problem. 
The complicacy and difficultness of the asthma control assessment as an integral parameter 
under conditions of the real practice cause the necessity of introducing and using adequate and 
effective instruments. 
For today in clinical studies and everyday practice well proved clinical instruments for 
the symptoms assessment are used: asthma control test (АСТ) and asthma control questionnaire 
(ACQ), that allows to estimate the condition of asthma control in points using the easy but objective 
method, in a short period of time taking into account most important symptoms. These tests are 
reliable instruments of the monitoring of the condition of patients with BA, and treatment effec-
tiveness assessment. 
BA control test (АСТ) is the questionnaire, easy for the use and calculation, which data by 
the results of examinations well correlate with doctors’ assessment by the data of the disease an-
amnesis, physical examination and measuring of the external breath function, and also with ACQ 
results [7, 8]. 
АСТ includes 5 questions, connected with symptoms, frequency of using bronchodilators 
of a short-term action, and self-assessment of the BA control level. The scale of points from 1 to 5 
is offered for answers. At summarizing points the result ≤19 indicates an uncontrolled BA, 20 and 
more points – a controlled clinical course. 
ACQ is a reliable instrument that allows to estimate the BA control exactly and with repro-
duction [10]. The data of independent studies give proofs about validity of the questionnaire for BA 
control, and the possibility of its use in the general practice and for clinical studies [11, 12]. The 
questionnaire includes questions about BA symptoms, use of bronchodilators with a short-term 
action (ACQ-6), and also the volume of a forced exhalation for 1 second (FEV1) (ACQ-7) [13]. Re-
sults of answers to 6 or 7 questions (depending on a possibility to study the external breath function 
(EBF)) are averaged for receiving the final index. For determining the control level, 2 threshold 
values were described. The mark ≤0,75 points means that BA is controlled, and the value ≥1,5 – un-
controlled [11]. The interval from 0,75 to 1,5 – so-called “grey zone”, from our point of view, it may 
be assessed as a partial control of asthma. 
For estimating COPD symptoms, COPD assessment test (САТ) is offered. It allows to es-
timate an influence, caused by the disease on patients’ health condition and life quality [14, 15]. 
The test includes 8 items, which answers vary from 0– no problem, to 5 – maximally expressed 
problem. The questions reflect different aspects of the health condition worsening at COPD. The 
general sum of points may be from 0 (the best index) to 40 (the worst index); closely correlates 
with the health status, measured according to the questionnaire of St. George hospital [16]. САТ 
points 0−10, 11−20, 21−30 and 31−40 represent, light, moderate, severe or very severe clinical 
course of the disease. 
For today the disease control assessment and clinical factors, conditioned by BA+COPD 
association, are insufficiently studied. 
2. Aim of research
The control determination and symptoms assessment of patients with BA and COPD associ-
ation, who undergo the usual basic therapy according to the disease severity degree. 
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3. Materials and methods
The study included patients with signs of both diseases – bronchial asthma and COPD, old-
er 30 years. The diagnosis asthma and COPD was set by criteria, presented in GINA and GOLD 
[17, 18]. The patients’ condition was stable, exacerbations were absent for 2 months before the 
beginning of the study. 
The association of asthma and COPD was proved by the results of the study of the external 
breath function (EBF) – in all patients was detected the fixed disorder of the respiratory tracts 
permeability – ratio of a forced exhalation volume for the first second/ force vital capacity of lungs 
(FEV1/FVC) <70 % after a bronchodilator (conventional COPD marker) and the reverse character 
of bronchial obstruction –  FEV1 increment by ≥12 % and ≥200 ml after using a bronchodilator 
(400 mcg of salbutamol), is usually more inherent to the bronchial asthma. 
The study included patients with the bronchial asthma and COPD without pathologies asso-
ciation signs as a control. 
Patients underwent the standard basic therapy of BA and COPD according to the disease se-
verity degree, all took β2-agonists of a short action (STBA) at the necessity and preparations for the 
disease control: (inhalation corticosteroids ICS), combination ICS+β2-antagonists of a long action 
(LABA), tiotropium bromide or the triple therapy – ICS/LABA, tiotropium bromide. 
Characteristic of patients is presented in Table 1. 
Table 1
Characteristic of patients
Parameters BA (n=34) COPD (n =17) BA+COPD (n =140)
Sex, n 27 women, 7 men 7 women, 10 men 74 women, 66 men
Age, years 50,76±1,5 67,36±2,27 58,56±0,81
Body mass index, kg/m² 31,64±1,39 30,02±1,46 28,82±0,43
Smoking period pack/years  2,87±1,28 8,06±3,28 10,35±1,77
Ex-smokers, % 12 18 7
Smokers, % 20 29 34
Never smoked, % 68 53 59
BA severity degree
light, % 32 6
Middle severity, % 59 79
severe, % 9 15
Groups of patients with COPD
A, % 18 13
B, % 11 21
C, % 18 20
D, % 53 46
Bronchial obstruction severity degree 
GOLD
1, % 29 29
2, % 29 58
3, % 36 11
4, % 6 2
Therapy before inclusion in the study 
SABA, if necessary, % 100 100 100
ICS, % 15 12 6
ICS/LABA, % 85 88 89
Tiotropium bromide, % 0 12 3
ICS/LABA, tiotropium bromide, % 0 0 2
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For determining the presence and severity degree of the bronchial obstruction, all patients 
underwent the spirometry with the analysis of the curve “flow-volume” of a forced exhalation and 
also the bodypletizmography on the set for the respiratory system study “MasterScreenPneumo”, 
2007, made by “CardinalHealth” (Germany).
All patients were interrogated by the questionnaires: BA symptoms control questionnaire 
(ACQ-7), BA control test (ACT), COPD assessment test (CAT).
The accumulation of data and their mathematical processing were realized using licensed 
program products, included in the package Micrоsoft Office Professional 2007, license RussianAc-
ademic OPEN NoLevel No. 43437596. The statistical processing was realized using mathemati-
cal and statistical possibilities of MS Excel, and also additional statistical function, elaborated by 
S. N. Lapach, A. V. Chubenko, P. N. Babych [19]. The parameters, investigated in the study, were 
assessed using the determination of the mean value (М), mistake of the mean value (m), reliabil-
ity criterion (t), importance level (р), with the further comparison using Student t-criterion and 
Mann-Whitney U-criterion depending on the distribution type of received data. The checking of 
numerical lines for the correspondence to the normal distribution was realized using the special 
NORMSAMP_1 functions, developed for Excel program [19].
4. Results
At comparing parameters of BA control was revealed the reliably worse control in the group 
of patients with the associated pathology by data of the questionnaire ACQ-7 comparing with pa-
tients with BA. The influence of COPD symptoms was also more essential in patients with ACC 
comparing with ones with COPD. 
So, the association of two nosologies had a negative influence on both BA control degree and 
COPD symptoms expressiveness. The data are presented on Fig. 1, 2. 
 
Fig. 1. General calculation of АСТ and САТ in studied patients:  
* – p<0,05; ** – p<0,01 comparing with BA
 
Fig. 2. General calculation of АСQ-7 in studied patients: 
* – p<0,05; ** – p<0,01 comparing with BA
There was also analyzed, what part of patients from BA and ACC groups had BA control 
and of what degree (Fig. 3, 4). 
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Fig 3. Distribution of patients with BA and ACC by BA control level according to АСТ 
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Fig. 4. Distribution of patients with BA and ACC by BA control level according to ACQ-7
The part of patients with ACC, in whom the good asthma control was detected by both 
АСТ and АСQ-7 results, is essentially less than at the single BA (АСТ ≥20 points was in 14 % 
of patients with ACC against 26 % – at BA without an association and АСQ-7 ≥1,5 points – in 
2 % against 12 %). 
It testifies to the essential contribution of the concomitant COPD in the weaker BA con-
trol in patients with the associated pathology. A doctor-practician must assess the condition and 
symptoms of the disease more accurately especially at such co-morbid pathology, start the rational 
therapy as early as possible, because it is well-known, that it may essentially influence the disease 
prognosis. 
There was also analyzed the influence of COPD symptoms on the condition of patients with 
ACC and COPD. The moderate and essential influence was revealed in 88 % of patients with COPD 
and in 93 % of patients with the associated pathology. The data are demonstrated on Fig. 5. 
 
Fig. 5. Distribution by COPD influence degree on patients’ life
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The following task of the study was the determination of the control level and influence of 
BA and COPD association on the condition of patients’ with the associated pathology depending on 
the bronchial obstruction severity degree. 
The distribution of patients by the degree of the bronchial obstruction intensity was realized 
according to the spirometric classification of GOLD (Table 2) [17]. 
Table 2
Classification of the bronchial obstruction severity at COPD by FEV1 level after taking a broncholytic 
(GOLD, 2017)
Degree FEV1 indices, % of proper ones
GOLD 1 (light) FEV1³80 %
GOLD 2 (moderate) 50 £FEV1<80 %
GOLD 3 (severe) 30 £FEV1<50 %
GOLD 4 (vey severe) FEV1<30 %
Because the group GOLD 4 included only 2 patients, groups 3 and 4 were combined for the 
data analysis. At the more expressed bronchial obstruction degree BA control was reliably weaker, 
whereas an influence of COPD symptoms more essential. 
The indices of the control and disease influence on the life of patients with ACC depending 
on the bronchial obstruction degree are presented on Fig. 6, 7. 
 
Fig. 6. Control degree and intensity of symptoms (АСТ and САТ) of patients  
with ACC comparing with the bronchial destruction degree: * – p<0,05;  
** – p<0,01 comparing with GOLD 1
For assessing the patients’ condition and prognosticating risk of death from any case and 
from the pulmonary pathology in patients with the bronchial pulmonary pathology, BODE index 
is widely used in the world: it is a multiparametric system of point assessment of a condition of a 
patient with COPD [20, 21].
For assessing the risk of a worse prognosis in patients with BA+COPD using BODE index 
determination (BODE≥2), the chance ratio was calculated in patients with the severe and very se-
vere COPD degree (САТ≥20 points). The index of the chance ratio was 2,39 and had 95 % reliable 
interval within 1,13−5,08 (р<0,05). It testifies to the fact that in patients with САТ index ≥20, the 
mortality prognosis, expressed by BODE index, grows more than twice. So, there is demonstrated 
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the high connection of COPD symptoms and disease prognosis in patients with the associated pa-
thology BA+COPD.
 
Fig. 7. Control degree (АСQ) of patients with ACC depending of the bronchial destruction level: 
* – p<0,05; ** – p<0,01 comparing with GOLD 1
At assessing the worse prognosis of COPD in patients with BA+COPD and the unsatisfac-
tory BA (АСТ<20 points), the change ratio index was 2,72 and had 95 % reliable interval within 
1,04 to 7,14 (р<0,05). It testifies to the fact that in patients with ACC with the low BA control, the 
mortality prognosis, expressed by BODE index grows more than in 2,5 times. After using АСQ-7 
questionnaire (bad control ≥1,5 points) −  the chance ratio was 2,96 at the 95 % reliable interval 
within 1,11 to 7,94 (р<0,05). That is in patients with the unsatisfactory BA control, according to 
АСQ-7, the mortality prognosis by BODE index grows almost in 3 times. 
Thus, there was revealed the essential negative influence of the insufficient BA control and 
strong influence of COPD symptoms on the disease prognosis in patients with the associated pa-
thology BA+COPD.
The symptoms severity and limitation of everyday activity of patients with the bronchial 
obstructive pathology are conditioned by the inability to breathe fully. Asthma and COPD are 
usually attended with EBF changes, manifested by the respiratory tracts permeability disorder, 
hyperactivity of respiratory tracts at COPD, and at the long clinical course of asthma – by the fixed 
bronchial obstruction, signs of pulmonary hyperinflation and so on [22, 23]. 
The correlative analysis between the indices of COPD influence on the condition of patients 
with ACC (by САТ) and EBF was realized. 
The reliable positive correlation was revealed between the point by САТ and ratio of the 
internal thoracic gases volume to the general lung capacity (ITGV/TLС), that reflects the degree of 
lungs hyperinflation − (r=0,35; p<0,05) (Fig. 8).
 Fig. 8. The correlative analysis of CAT point and EBF indices 
It proves the fact that the more COPD influence degree on the condition of patients with 
ACC, the more expressed hyperinflation signs of these patients are. 
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5. Discussion
There is an essential layer of data about the influence of COPD symptoms, bad BA control 
on the prognosis, life quality of patients with BA and COPD. But for today there is not enough data 
in the literature about the role of the severity and control of the disease at the associated bronchial 
obstructive pathology. 
At this study the combination of two nosologies had a negative influence on both BA control 
degree and COPD symptoms intensity. Both the disease control and symptoms intensity degree 
were more expressed just in patients with the associated bronchial obstructive pathology. 
At the analysis of data of the questionnaires of patients with ACC depending on the bronchi-
al destruction level, the data were received about the reliably weaker control and essential influence 
of COPD symptoms in patients with the more disease severity level. 
Using the assessment by BODE index, there was demonstrated the close connection be-
tween the CAT point and negative prognosis at the associated bronchial obstructive pathology. The 
disease prognosis essenrially depended on the BA control degree. 
The received data allow to make an accent on the other important presupposition in the BA 
control in patients with the associated bronchial obstructive pathology, attended by the strong in-
fluence of COPD symptoms on patients’ everyday life and also by the reliably worse disease prog-
nosis. In the clinical practice such patients must be supervised taking into account these important 
features of this pathological state. 
6. Conclusions
1. At the BA and COPD association, indices of the diseases control are worse than at the 
bronchial asthma and a bit similar to ones at COPD. 
2. The indices of the BA control, COPD symptoms influence on the condition of patients 
with the associated bronchial obstructive pathology were mainly negatively changed at the increase 
of the bronchial obstruction degree. 
3. In patients with ACC with the unsatisfactory BA control (АСQ-7≥1,5 points) the mortality 
prognosis, expressed by BODE index, grows more than in 3 times; in patients with the severe and 
very severe influence of the disease effect (САТ>20 points), the mortality prognosis increases more 
than twice. 
4. The special attention must be paid just to patients with the associated bronchial obstruc-
tive pathology to prevent complications and improve the disease prognosis; the other important 
task in the treatment of the associated bronchial obstructive pathology is an attainment of BA and 
timely and complete therapy for decreasing symptoms and risk factors of undesirable results of 
both pathological states. 
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